Actively Recruiting

Age: 18Years - 79Years
All Genders
NCT04703166

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

Led by Tulane University School of Medicine · Updated on 2025-04-17

360

Participants Needed

1

Research Sites

138 weeks

Total Duration

On this page

Sponsors

T

Tulane University School of Medicine

Lead Sponsor

S

Samsung

Collaborating Sponsor

AI-Summary

What this Trial Is About

To evaluate the progression of atrial myopathy through wearable devices and cardiac imaging.

CONDITIONS

Official Title

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

Who Can Participate

Age: 18Years - 79Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants aged 18 to 79 years with atrial fibrillation, or participants aged 40 to 79 years at moderate or high cardiovascular disease risk
  • Access to internet and email at home
  • Access to a compatible Android mobile device or an iPhone 4S or newer, or iPad 3 or newer
  • Ability and willingness to return to the study clinic for a follow-up appointment and MRI scan one year after baseline
  • Ability to read, understand, and sign the consent form
Not Eligible

You will not qualify if you...

  • Any health-related contraindications to gadolinium or MRI (e.g., allergy, pacemakers, implantable defibrillators, or other implants)
  • Weighing more than 300 lbs (due to decreased MRI quality)
  • Renal insufficiency with GFR less than 30 mL/min/1.73 m2 or acute/severe kidney disease
  • Women who are pregnant at enrollment (no MRI if pregnant during study until 10 days postpartum)
  • No access to internet or email
  • No compatible Android or iOS mobile device
  • Cognitive impairments affecting ability to use and maintain wearable devices
  • Unable or unwilling to return for the one-year follow-up clinic visit and MRI
  • Cognitive impairments preventing informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tulane University School of Medicine

New Orleans, Louisiana, United States, 70112

Actively Recruiting

Loading map...

Research Team

Q

Quintrele Jones, MPH

CONTACT

C

Chris Wang, MS

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy. | DecenTrialz